Atopix Competitors and Similar CompaniesClear all

Atopix's competitors and similar companies include AKESOgen and Akebia Therapeutics.
Atopix
Atopix
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK
AKESOgen
AKESOgen
AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural
Akebia Therapeutics
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Founding Date
Founding Date
2012
Founding Date
2010
Founding Date
2007
Type
Type
Private
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Milton, GB HQ
Locations
Norcross, US HQ
Locations
Cambridge, US HQ
Employees
Employees
N/A
Employees
6
Employees
324187% increase

Financial

Revenue (est.)
Revenue (est.)
£453.4k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$236.2m (FY, 2025)
Net income
Net income
£592.1k (FY, 2017)
Net income
N/A
Net income
($5.3m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 5.1m
Total funding raised
$ 1.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

AKESOgen
HQ
Norcross, US

AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural

View company
Akebia Therapeutics
HQ
Cambridge, US
Employees
324

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

View company